http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09119931-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_251e1845f2afb83192254fcce85de629 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 1995-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b63bd541ddef4c614291c0cd2b7c03cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_932edac9c68d4b2cea2e835d6d8a3600 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50c463da36cd70c189fb92661e668d3c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e427938c02ccebc11ceec93ebcc2b6fc |
| publicationDate | 1997-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H09119931-A |
| titleOfInvention | Method for stabilizing blood proteins coexisting with fecal components |
| abstract | (57) Abstract: An object of the present invention is to provide a novel substance that protects blood proteins that coexist with fecal components. This protected material is effective against an unknown denaturing / degrading action for which a sufficient effect cannot be expected with a known stabilizer. The present invention provides a blood protein stabilization technique that coexists with a fecal component, utilizing an inhibitor for the component characterized by the following properties a) -c). a) contained in normal human feces b) having the activity of reducing the antigenicity of blood proteins c) contained in the filtrate when this component is dissolved and filtered through a membrane filter having a pore size of 5 μm [effect] According to the present invention, blood proteins such as hemoglobin present in fecal suspensions can be effectively stabilized. The present invention is a technique which is particularly excellent in the protective effect of hemoglobin antigenicity and is useful for stabilizing hemoglobin as an immunological analysis target. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009085685-A |
| priorityDate | 1995-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 167.